Join us to discover strategies to de-risk, optimize and accelerate your journey 'from I to I': from Idea to IND/IMPD, from early development to the clinic, while exploring case studies of successful programs.
Date:
Monday, 14 October 2024
Time:
14:00–19:30 CEST
Location:
You are invited to Lonza’s i2i Academy, featuring an informative and engaging keynote, fireside chat and insightful case studies from companies like yours to secure and accelerate your path to clinic.
Join us to learn from Lonza experts and other industry leaders about the exciting road of bringing an idea to a successful IND/IMPD submission, for mammalian-derived biopharmaceuticals, including bioconjugates, for both drug substance and drug product. Strategies to overcome funding, regulatory, technical and technological challenges will also be addressed.
Join us to learn from Lonza experts and other industry leaders about the exciting road of bringing an idea to a successful IND/IMPD submission, for mammalian-derived biopharmaceuticals, including bioconjugates, for both drug substance and drug product. Strategies to overcome funding, regulatory, technical and technological challenges will also be addressed.
Receive a tour of Lonza's drug product development services facilities featuring state-of-the art formulation, process development, preclinical manufacturing and particle analysis labs.
Following the afternoon programming, we will host a ribbon cutting ceremony to officially open Lonza Stucki’s new Building H focused on GMP analytics. A networking reception with food and drinks will follow the i2i Academy and ribbon cutting ceremony.
Registration for this event is at capacity and we are no longer accepting registrations. Please visit our website for other Lonza events.
